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The level of expression of conjugation genes in Enterococcus faecalis strains carrying the pheromone-
responsive transferable plasmid pCF10 is determined by the ratio in the culture medium of two types of
signaling peptides, a pheromone (cCF10) and an inhibitor (iCF10). Recent data have demonstrated that both
peptides target the cytoplasmic receptor protein PrgX. However, the relative importance of the interaction of
these peptides with the pCF10 protein PrgZ (which enhances import of cCF10) versus PrgX is not fully
understood, and there is relatively little information about specific amino acid sequence determinants affecting
the functional interactions of cCF10 with these proteins in vivo. To address these issues, we used a pheromone-
inducible reporter gene system where various combinations of PrgX and PrgZ could be expressed in an isogenic
host background to examine the biological activities of cCF10, iCF10, and variants of cCF10 isolated in a
genetic screen. The results suggest that most of the amino acid sequence determinants of cCF10 pheromone
activity affect interactions between the peptide and PrgX, although some sequence variants that affected
peptide/PrgZ interactions were also identified. The results provide functional data to complement ongoing
structural studies of PrgX and increase our understanding of the functional interactions of cCF10 and iCF10
with the pheromone-sensing machinery of pCF10.
Enterococcus faecalis strains frequently harbor transmissible
plasmids whose conjugation functions are regulated by extra-
cellular signaling peptides (15, 17). In contrast to peptide sig-
naling systems where a two-component signal transduction
phosphorelay activates a cellular response upon peptide bind-
ing to the cell surface, the enterococcal pheromones must be
imported into responder cells by the concerted action of a
plasmid-encoded pheromone binding protein and the chromo-
somal oligopeptide permease system Opp (33). Initial studies
of these plasmids suggested a unidirectional communication
circuit where a mating pheromone produced by plasmid-free
recipient cells was specifically sensed by the plasmid-contain-
ing donor cells (19, 21). This model is insufficient because
pheromone production ability is encoded by the chromosome
(13), implying that a plasmid-containing cell must avoid self-
induction by its own endogenous pheromone while retaining
the ability to sense the same pheromone from an exogenous
source. Subsequent studies of several different pheromone
plasmids suggested that, in addition to sensing exogenous
pheromone, the inducibility of these systems also depends on
two plasmid-encoded gene products, a membrane protein that
partially shuts down or inactivates pheromone produced by
donor cells (1, 8, 37) and an inhibitor peptide which reduces
the activity of pheromone in solution (14, 16, 36, 38). The
inhibitor appears to function in donor cells by neutralizing the
endogenously produced pheromone that escapes the phero-
mone reduction activity of the membrane protein. Both gene
products are required to prevent the donor cell from a wasteful
constitutive self-induction of conjugation in the absence of
recipients. In the case of plasmid pCF10, conjugation is posi-
tively regulated by the pheromone peptide cCF10 (35) and is
negatively regulated by the inhibitor peptide iCF10 (38). The
level of endogenous pheromone production by pCF10-contain-
ing donor cells is reduced by the PrgY membrane protein (8,
9). Ultimately, the induction state of a pCF10-containing
donor cell depends on the molar ratio of the two peptides in
the growth medium rather than the absolute pheromone
concentration; the mechanism by which inhibitors inhibit
pheromones is not completely clear. A model depicting the
major peptide-mediated control circuits in the pCF10 sys-
tem is shown in Fig. 1A.
An extensive series of genetic, biochemical and structural
studies has shown that the 317-amino-acid protein PrgX is the
cytoplasmic pheromone-responsive molecular switch of the
pCF10 system (4–7, 29, 30, 39). PrgX controls expression of
conjugation by negative regulation of the promoter of the prgQ
operon, encoding the pCF10 conjugation machinery. It has
been proposed that repression of prgQ transcription by PrgX is
mediated by a mechanism involving PrgX occupancy of two
relatively weak binding sites in pCF10 DNA (6), with a dimer
bound to each site (39). Binding is predicted to be stabilized by
protein/protein interactions between pairs of PrgX dimers and
by formation of a DNA loop between the two PrgX binding
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sites (29, 39). Determination of high-resolution structures of
PrgX and PrgX/cCF10 complexes indicated that a PrgX C-
terminal loop (residues 287 to 294) comprising the major in-
terface holding tetramers together in the apoprotein structure
would be moved as a result of pheromone binding (39). The
observed changes the crystal structure would likely destabilize
tetramers in solution; our initial structural data also led to the
prediction that iCF10 might bind the same pocket of PrgX but
not cause the tetramer-destabilizing movement of the C-ter-
minal loop. Figure 1B depicts the oligomeric structure of PrgX
complexed with either iCF10 or cCF10, based on the data just
presented and those described in the following paragraph.
Previously published literature suggested that the primary
site of competition between the inhibitor and pheromone pep-
tides might be the extracellular pheromone binding proteins
(PrgZ in the pCF10 system and TraC in the case of plasmids
pAD1 and pPD1) (17) that enhance pheromone uptake at low
concentrations, but there was little direct evidence to support
this contention. Very recently, we have shown that both cCF10
and iCF10 target PrgX (30). New structural data show that
both proteins bind to the same region of PrgX but produce
different conformational changes (30). As noted above, in the
case of cCF10 binding (39), a subdomain of PrgX immediately
adjacent to the loop encompassing residues 287 to 294 changes
its structure dramatically. This is due to direct interactions
between the bound pheromone and residues 296 to 299 of
PrgX. Our recent data (30)show that in iCF10/PrgX com-
plexes, PrgX residues 312 to 315 interact with the bound in-
hibitor, actually locking the loop encompassing residues 287 to
294 into a tetramer-promoting conformation. In light of these
recent data, the extent to which direct interactions of cCF10
and iCF10 with PrgZ modulate the biological activities of these
peptides is less clear. In addition, the means by which the
specific amino acid sequences of these peptides determine
their biological activities are not fully understood.
In the course of several studies of the pCF10 system (6, 7, 10,
29, 30), we have generated isogenic sets of strains containing a
transcriptional reporter gene fused to the pheromone-induc-
ible prgQ promoter and expressing various combinations of
prgX, prgY, and prgZ in order to better understand the inter-
actions between the products of these genes and the regulatory
peptides. Here we report the use of similar reporter strains in
a series of genetic and physiological experiments designed to
complement recent structural studies (30, 39) by providing
data on the functional interactions of cCF10 and iCF10 with
the PrgX and PrgZ proteins. We also describe a genetic screen
to identify peptide variants of cCF10 with altered biological
activities, and we examine the extent to which PrgX and PrgZ
affect these activities. The results suggest that the amino acid
sequence determinants affecting interactions with PrgX are
most important in the activities of both pheromone and inhib-
itor peptides. Comparative analysis of native and variant pep-
tides also revealed amino acid residues of cCF10 that were
important for efficient PrgZ-mediated import.
MATERIALS AND METHODS
Bacterial strains, plasmids, and reagents. E. faecalis was grown at 37°C either
in Todd-Hewitt broth (Difco), in M9-YE glucose medium (20) (an M9-based
medium supplemented with 0.3% yeast extract, 1% Casamino Acids, 0.1% glu-
cose, 1 mM MgSO4, and 0.1 mM CaCl2), or on Todd-Hewitt broth plates
containing 1.5% agar. Antibiotics were used at the following concentrations:
tetracycline, 10 g/ml; erythromycin, 10 g/ml; chloramphenicol, 20 g/ml; ri-
fampin, 200 g/ml; kanamycin, 1,000 g/ml; and fuscidic acid, 25 g/ml. Esche-
richia coli DH5 was used for cloning purposes and was grown in Luria-Bertani
(LB) broth at 37°C with antibiotics at the following concentrations: erythromy-
cin, 200 g/ml; kanamycin, 50 g/ml; and spectinomycin, 50 g/ml. All bacterial
strains and plasmids used in this study are summarized in Table 1. Plasmid
pPCR-4, used for mutagenesis of the cCF10-coding sequence, contains the
pCF10 prgQ gene cloned into the vector pDL278 with the 3 sequence altered to
encode cCF10 instead of the native iCF10 (8, 38). The plasmid pMSP6043-1
expresses PrgZ from a pCF10-derived carrying encoding prgN, -O, -P, -W, and -Z
cloned into the vector pDL27 (9); pMSP6043-2, which does not express PrgZ,
was made by ligating the EcoRI and PstI fragment from prgN through the middle
of prgZ from pINY6023 into the EcoRI and PstI sites of pDL276 in the same
orientation as that of pMSP6043-1. Kristich et al. (31) have recently described
the integration of the pWV01 repA gene under control of a lactococcal promoter
into the upp locus of the E. faecalis chromosome by homologous recombination
using an integrative plasmid called pCJK20, where the cloned gene to be inte-
grated is flanked by the 5 and 3 segments of upp to promote recombination. To
construct an OG1S derivative with an expressed prgX gene integrated into the
chromosome for this study, we used a vector plasmid, pCJK41, that is virtually
identical to pCJK20 except that it contains a minor change in the ribosome
binding site driving expression of the cloned gene (the sequence from the ribo-
FIG. 1. Extracellular (A) and intracellular (B) peptide-mediated con-
trol circuits in the pCF10 system. (A) Pheromone cCF10 (LVTLVFV) is
produced (double arrows) from the chromosome (thin line with bro-
ken end) by proteolytic processing of the chromosomal ccfA gene
product (3), whereas inhibitor iCF10 (AITLIFI) is produced by pro-
cessing of the polypeptide encoded by the prgQ gene (38) of pCF10
(thin circle); prgQ is actually the first gene in a long, pheromone-
inducible conjugation operon. Either endogenously produced or exog-
enous cCF10 pheromone can induce expression of Asc10 and other
pCF10-encoded conjugation gene products. Pheromone activity of
cCF10 is inhibited by iCF10, but previous work has not fully elucidated
whether this occurs inside the cell, outside the cell, or in both locations.
In a plasmid-containing donor cell, the pCF10-encoded PrgY protein
reduces the amount of cCF10 produced, and the cell produces enough
iCF10 to neutralize the residual cCF10 that escapes PrgY control (9,
10, 25); this precise balance in opposing activities can be shifted by
addition of exogenous cCF10 from recipient cells. (B) Working model
for the function of PrgX as the intracellular switch controlling phero-
mone-inducible conjugation. The protein consists of an N-terminal
DNA binding domain (oval) connected by a flexible linker to a central
dimerization domain (filled box), which also contains a peptide binding
pocket (39). When cCF10 pheromone occupies this pocket, the PrgX
C-terminal regulatory domain (represented by a thin, curved line)
undergoes a marked shift to allow for interactions of amino acids
between positions 295 and 300 with the bound peptide; this displaces
a loop in this domain (residues 287 to 294) that is important for PrgX
tetramer formation (39). In complexes with iCF10, PrgX amino acids
between residues 311 and 315 interact with the bound peptide; this
actually stabilizes the position of the tetramer-promoting loop. Tet-
ramers of PrgX are predicted to simultaneously bind two operator sites
in pCF10 DNA more stably than a pair of unlinked dimers. One of
these operators overlaps the prgQ promoter, such that conjugation is
repressed when it is occupied by PrgX (6, 7).
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some binding site to the prgX start codon of the construct used here is AGGA
GGTATTATTACATG). The desired integration of prgX into the upp locus was
confirmed by PCR and sequencing, and we confirmed expression of levels of
PrgX protein comparable to those of cells carrying pCF10 by Western blot
analysis (4).
Oligonucleotide-directed random mutagenesis and screening. Oligonucleo-
tide-directed random mutagenesis was carried out using Invitrogen’s GeneTailor
site-directed mutagenesis system. In this process, base substitutions in the cCF10
sequence were made using the mutagenic primer prgQ-ccfA degenerate, with the
sequence 5-TCA AGA TAT ATA GCT GTT GTA ATT TTA GTA ACC TTA
GTA TTT GTC TGA TAG AAT TC-3 (boldface indicates the degenerate
portion), and the primer prgQ-2 rev, with the sequence 5-TTA CAA CAG CTA
TAT ATC TTG ATA G-3. These mutagenic primers were synthesized using the
five-bottle method described by Chiang (11) In this process, when the nucleotide
targeted for mutagenesis is reached during primer synthesis, the wild-type nu-
cleotide is mixed with a specific concentration of each of the non-wild-type
nucleotides such that a certain percentage of misincorporation occurs (11). For
this experiment, 2.5% misincorporation was used, meaning that each non-wild-
type nucleotide had a 2.5% chance of being replaced at a given position. The
coding sequences and locations of primers used for this oligonucleotide-directed
random mutagenesis strategy are outlined in Fig. 2. The resulting PCR-gener-
ated mutated plasmids were then transformed into E. coli DH5-T1R cells
(Invitrogen) and screened for production of cCF10 with altered activity.
In E. coli, pPCR-4-produced cCF10 and the mutants are secreted into the
surrounding medium. The peptides produced were then screened to identify
those with altered activity by using an E. faecalis based-clumping assay (see
below). E. coli clones whose supernatants showed altered activity compared with
clones expressing wild-type cCF10 were sequenced to determine the amino acid
substitutions giving the resulting activity. We determined the sequence of about
300 to 400 bp of plasmid DNA spanning the region from the upstream end of the
prgQ promoter to about 200 bp downstream from the peptide-coding region. The
only mutations detected were in the region where degenerate bases were incor-
porated into the mutagenic primers. The deduced peptides of selected plasmids
from E. coli clones whose supernatants showed altered but not abolished activity
were synthesized chemically (Mimotopes, Raleigh, NC) to further examine their
activity.
Clumping assay. The fact that pheromone induction can be detected by the
formation of visible clumps in donor cell cultures exposed to the peptide (35)
served as the basis for the biological assay used to screen mutants. E. coli strains
harboring mutated plasmids were individually grown in LB medium for 15 h, and
the cells were then centrifuged for 10 min at 11,000  g and the pheromone
activity in the supernatant was assayed. One hundred microliters of the super-
natant was added to the first well of a microtiter plate, and twofold serial
dilutions were made across a row of wells. Then 10 l of an overnight culture of
E. faecalis OGIRF(pCF10) was added to each well, and the plate was incubated
at 37°C with shaking for 2 hours. Culture supernatant from E. coli DH5-
T1R(pPCR-4) was used as a positive control, and wells containing the indicator
strain OGIRF(pCF10) and medium were used as a negative control. Pheromone
activity was reported as the titer, which is the reciprocal of the highest twofold
dilution showing a positive clumping reaction.
-Galactosidase assay. Derivatives of E. faecalis OG1RF carrying p043lacZ,
containing a pheromone-inducible prgQ-lacZ transcriptional fusion (29) and in
some cases a second plasmid (pMSP6043-1, described above) expressing prgZ,
were grown overnight in M9-YE medium and then diluted 1:5 into fresh M9-YE
medium and grown for an additional 1.5 h before harvesting for -galactosidase
assay. When indicated, strains were induced immediately after the 1:5 dilution
with the indicated concentration of synthetic cCF10, iCF10, or mutated peptide.
-Galactosidase assays were performed as described previously (29). Results
shown are representative of at least two independent experiments done in du-
plicate on different days.
RESULTS
PrgZ increases sensitivity to pheromone, while PrgX is re-
quired for the response to both pheromone and inhibitor.
Several previous studies (7, 29, 30) have employed plasmid
p043lacZ, containing a pheromone-inducible prgQ-lacZ tran-
scriptional reporter gene fusion as a “minimal” genetic system
for detailed analysis of the pheromone-sensitive repression of
the prgQ promoter by PrgX in E. faecalis. This system has
proven to be very useful in genetic studies and in quantitative
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s) or description Reference or source
Strains
E. coli DH5 Cloning host Invitrogen
E. faecalis
OG1RF Rif r Far; derived from clinical strain OG1 19
JRC104 cCF10-deficient OG1RF derivative 10
OG1Sp Spr; derived from clinical strain OG1 24
100-5 Derived from OG1Sp, carries chromosomal copy of prgX This study
Plasmids
pCF10 cCF10-inducible conjugative plasmid 18
pPCR-4 cCF10 expression construct derived from prgQ region cloned into pDL278 8, 38
p043lacZ pAT18 vector containing prgX-Q region of pCF10 with a pheromone-inducible lacZ reporter gene 29
p043lacZ dX No PrgX protein produced, control strain 30
pMSP6043-1 prgN, -O, -P, -W, and -Z in pDL276 9
pMSP6043-2 prgN, -O, -P, and -W in pDL276 This study
FIG. 2. Diagram of pheromone-coding sequence (66 bp) and prim-
ers used for oligonucleotide-directed random mutagenesis of plasmid
pPCR-4. The coding sequence is derived from the prgQ open reading
frame in pCF10 and includes the prgQ promoter (PQ) and altered
coding sequence so that cCF10 is expressed instead of the native iCF10
(indicated in checked region of the arrow); the complete DNA se-
quence for the start codon, the pheromone-coding region, and the four
codons immediately upstream is shown. Primers used for random PCR
mutagenesis are indicated below; the bracketed region of the prgQ-
ccfA degenerate primer indicates the region directed for degenerate
base incorporation (see Materials and Methods).
VOL. 189, 2007 SPECIFICITY OF PrgX AND PrgZ FOR cCF10 1401
 on N
ovem







analysis of the effects of pheromone induction on PrgX-regu-
lated prgQ transcription in vivo. However, the high copy num-
ber of the vector plasmid and the resulting high levels of
expression of the negative regulatory elements PrgX and
iCF10 make it necessary to use higher levels of pheromone to
obtain induction (7, 29, 30), relative to the amounts required to
induce cells containing pCF10. We wished to employ this sys-
tem for the analysis of cCF10 variants, as described below.
Therefore, we carried out experiments to confirm the critical
role of PrgX in interaction with both cCF10 and iCF10 in this
system and to determine the feasibility of using this system to
examine the effects of PrgZ on pheromone. We recently re-
ported (30) that a strain carrying p043lacZdX (containing a
prgX deletion removing 67% of the coding sequence from the
3 end) showed high-level constitutive expression of -galac-
tosidase and was unresponsive to cCF10 or iCF10 (Fig. 3A),
indicating that PrgX is essential for response to both peptides.
Due to a limited number of compatible cloning vectors and
instability of many chimeric plasmids carrying cloned prgX, we
have had limited success in carrying out genetic complemen-
tation of prgX mutations (7). To overcome this problem, prgX
was cloned into the chromosome where it is expressed consti-
tutively in strain 100-5 (see Materials and Methods), and this
strain was used to test whether the p043lacZdX plasmid phe-
notype could be complemented. The results demonstrated that
expression of a functional prgX in trans in a strain carrying
p043lacZdX fully restored (i) repression of prgQ in the absence
of exogenously added peptides, (ii) induction with exogenous
cCF10, and (iii) iCF10 inhibition of cCF10 induction (Fig. 3A).
In cells where the pheromone response genes of pCF10 are
carried on a low-copy replicon, PrgZ is required for an active
response to cCF10 in concentration ranges (1011 to 1012 M)
comparable to those found in recipient cell culture superna-
tants (33, 35). The defects in pheromone response associated
with deletion of prgZ could be overcome by addition of higher
concentrations of peptide, and it was concluded that the host
OppA peptide binding protein in conjunction with the rest of
the oligopeptide permease system could mediate cCF10 im-
port at higher peptide concentrations. Because induction of
(PrgZ) cells carrying only p043lacZ requires substantially
higher levels of pheromone, we wanted to determine whether
PrgZ could enhance the pheromone response at these higher
peptide levels. E. faecalis carrying p043lacZ along with either
pMSP6043-1 (conferring PrgZ expression) or pMSP6043-2
FIG. 3. Importance of PrgZ and PrgX in cCF10 response. (A) PrgX requirement for cCF10 response as shown by measuring -galactosidase
induction of plasmid p043lacZ carrying prgX (see text) or a an isogenic plasmid with a deletion in prgX, p043lacZ dX (dX), harbored by either a
wild-type strain (OG1Sp) or an isogenic strain with a chromosomal copy of prgX (100-5). Strains grown overnight in M9 medium were diluted 1:5
with no peptides added (black bars), or peptides were added as indicated. cCF10 was added at 10 ng/ml (dark gray bars), and in some cases iCF10
was also added at 10 times (100 ng/ml, light gray bars) or 100 times (1,000 ng/ml, white bars) the cCF10 concentration. (B and C) Response to
exogenously added cCF10 in the absence (vector control, gray bars) or presence (pMSP6043-1, white bars) of PrgZ. Cultures grown overnight in
M9 medium were diluted 1:5, and cCF10 was added in increasing amounts and harvested at 90 min (B) or added at 5 ng/ml and harvested at the
indicated time points (C). Data shown are representative of at least two independent experiments done in duplicate; error bars represent one
standard deviation of the mean.
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(vector control) was used in time course and dose-response
analyses. As shown in Fig. 3B and C, strains expressing PrgZ
had a higher response to cCF10 than strains expressing the
control at several different concentrations of cCF10 as well as
at different time points. While the relative increase in response
that was attributable to PrgZ was highest at the lowest phero-
mone level, there was a significant difference at all concentra-
tions tested; furthermore, the increase in induction observed in
the presence of PrgZ in the range of 3 to 5 ng/ml was compa-
rable to the previously observed increase of about twofold in
our study where the reporter genes were expressed from a
lower-copy replicon (33). In the time course studies we saw the
largest effect of PrgZ during a 90-min induction period. We
therefore used a 90-min induction period with 5 ng/ml peptide
to analyze the cCF10 variant peptides described in the follow-
ing section; we chose not to use a lower peptide concentration
because the significantly reduced activities of several of these
peptides would not generate a detectable response at lower
concentrations.
Construction of random cCF10 mutants and determination
of biological activity. To explore the cCF10 amino acid se-
quence determinants critical in the functional interactions with
PrgZ and PrgX, oligonucleotide-directed random mutagenesis
of a chimeric open reading frame encoding the cCF10 peptide
(Fig. 2) (see Materials and Methods) in the shuttle plasmid
pPCR-4 was performed. Both E. faecalis and E. coli cells car-
rying this plasmid excrete substantial quantities of cCF10 into
the culture medium. To screen these peptides for biological
activity, mutated pPCR-4 plasmids were transformed into E.
coli, and supernatant preparations from transformants were
screened for their ability to cause clumping of a wild-type
strain harboring pCF10 (see Materials and Methods). Prelim-
inary analysis indicated that a high percentage of clones ex-
pressing no clumping-inducing activity contained stop codons
and other severe mutations abolishing peptide production that
were uninteresting for our purposes. Therefore, we focused
our attention on those clones expressing altered but not abol-
ished activities indicative of production of a variant peptide
with amino acid substitutions.
Of 600 clones tested from three independent transforma-
tions, 14 unique mutations resulting in culture supernatants
yielding reduced activity were identified, and 1 unique muta-
tion (V7I) resulted in increased supernatant activity (Fig. 4).
Predicted amino acid substitutions resulting in decreased ac-
tivity were identified at each position along the cCF10 peptide.
Synthetic peptides were made for 10 representative peptides
and tested using the same clumping assay to ensure that the
observed effects were due to the inherent activity of the pep-
tide as opposed to differences in expression from the E. coli
host (Fig. 4). With the exception of V7I, the synthetic peptide
activity was similar to the E. coli-produced peptide activity. E.
coli supernatants from the strain encoding V7I had increased
activity compared with wild-type cCF10, whereas synthetic V7I
exhibited activity comparable to that of cCF10. The elevated
activity of E. coli-produced V7I may have been due to in-
creased synthesis or more efficient processing of this peptide,
but this was not investigated further. All of the peptide variants
identified in the genetic screen contained single amino acid
substitutions, with the exception of L4I,F6L. For this variant,
we also identified each of the corresponding single substitu-
tions in separate clones, and the activity of the double variant
was approximately what would be predicted from independent
additive effects of the single substitutions (Fig. 4). It was con-
sidered possible that some of the peptides with very low pher-
omone activity might actually act as cCF10 inhibitors, but we
were unable to detect any inhibitory activity when responder
cells were treated with mixtures of cCF10 and excess amounts
of the test peptides (data not shown).
PrgZ alters sensitivity of pheromone response to mutant
cCF10 peptides. A second test of peptide activity levels was
undertaken, which made use of plasmid p043lacZ. This plas-
mid was used as a reporter plasmid in a cCF10-negative host
strain JRC104 (to remove any confounding effects of endoge-
nous pheromone production by the responder strain), and the
ability of each peptide to induce -galactosidase expression
was determined. In the case of cCF10, the presence of PrgZ
increased the induction level by about 1.6-fold; most of the
variant peptides had significantly lower absolute inducing ac-
tivities, but the increase in activity associated with expression
of PrgZ was similar to that observed with cCF10 (Fig. 5). In
addition, the relative inducing activities of most of the variants
in the p043lacZ system were similar to those observed in the
clumping assays using pCF10-containing responders (Fig. 4
and 5). Three notable exceptions to this pattern were T3S,
F6Y, and V7I. In the absence of PrgZ, F6Y actually had a
higher inducing activity in the p043lacZ system than in the
pCF10 system (Fig. 5), whereas in the presence of PrgZ, cCF10
was more active, similar to the result obtained with pCF10
responder cells (Fig. 4). T3S showed a similar pattern, with a
higher activity relative to cCF10 in the absence of PrgZ. In
contrast, V7I had about two-thirds of the inducing activity of
cCF10 in the presence of PrgZ but much lower activity in the
absence of PrgZ (Fig. 4 and 5).
These results indicate that peptides T3S and F6Y may in-
teract with PrgX as well as cCF10 (or even better in the case of
F6Y), whereas the functional interaction of these peptides with
PrgZ leading to their import appears to be impaired. In con-
trast, the activities of peptide V7I suggest that the substitution
FIG. 4. Activity of cCF10 and variant peptides to induce clumping
of OG1RF(pCF10) cultures. Activity was measured as the reciprocal
of the highest dilution of E. coli-produced or synthetically derived
cCF10 or mutant derivatives to aggregate an OG1RF(pCF10) indica-
tor strain. The relative amounts of pheromone activity are represen-
tative of at least two independent experiments. The peptide LVTLVF-
(V7) was not found in the original assay but was synthesized and
tested in the clumping assay. Supernatants from E. coli strains express-
ing wild-type (WT) cCF10 (LVTLVFV) from pPCR-4 or each of the
mutant peptides were assayed for activity (light bars) following over-
night growth with aeration in LB medium. Activities of synthesized
peptides (dark bars) were assayed from twofold serial dilutions of a
50-ng/ml stock solution.
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of isoleucine for valine at the cCF10 C terminus resulted in a
less optimal interaction with PrgX, but this effect was partially
abrogated by a more efficient import of the peptide by PrgZ.
The importance of the C-terminal residue is also shown by the
fact that peptide V7 (this peptide was synthesized and tested,
though it was not identified in the genetic screen), comprised
of the first six residues of cCF10, exhibited a nearly undetect-
able pheromone activity (Fig. 4). From these data, we conclude
that productive interactions with both PrgX and PrgZ have
driven the evolution of the biological activity of the native
cCF10 sequence and that the specific peptide sequence deter-
minants for productive interaction with each protein do not
overlap completely.
DISCUSSION
Recent genetic, biochemical, and structural studies elucidat-
ing the molecular interactions between PrgX and both iCF10
and cCF10 (7, 29, 30, 39) have allowed the formulation of
detailed molecular models describing how the changes in PrgX
structure caused by peptide binding could alter the PrgX oli-
gomerization state in vivo and in turn affect PrgX-mediated
repression of the prgQ operon (7). While it is possible to use
molecular modeling to predict effects of specific amino acid
substitutions on the structure of the corresponding PrgX/
peptide complex, making accurate predictions of how these
changes might affect biological activity is more complicated
because the analysis of iCF10- and cCF10-containing com-
plexes has already shown that residues in different segments of
the PrgX C-terminal region can interact with different peptides
occupying the same binding pocket. Thus, one can use mod-
eling to test whether a given amino acid substitution would
disrupt interactions with PrgX C-terminal residues that inter-
act with cCF10, but it might be difficult to predict whether a
different set of C-terminal residues could interact with the
variant peptide. In addition, the biological activity of a given
peptide depends both on its interaction with PrgX and on the
PrgZ-mediated import of the peptide (which determines its
intracellular concentration). Therefore, we decided to take a
genetic approach to identify a collection of cCF10 variants with
altered biological activity, which could then be used in molec-
ular and structural studies to provide a more complete picture
of the pheromone-sensitive molecular switch controlling E.
faecalis conjugation. Since cCF10 pheromone activity is depen-
dent on interactions with both PrgZ and PrgX, we developed
the use of the p043lac reporter plasmid for pheromone induc-
tion. This facilitated expression of PrgZ in trans such that
effects of this protein on pheromone activity could be distin-
guished from effects on PrgX. In the course of experiments
(Fig. 3) to validate the system for the peptide mutagenesis
study, we confirmed recent evidence showing that PrgX is the
biologically significant target for iCF10 inhibition of cCF10
activity (31). While it had been suggested that the inhibitor
peptides might function by blocking pheromone import (22,
23), making inhibitor interactions with PrgX irrelevant, our
cumulative results indicate that PrgX/iCF10 interactions are
highly significant. As shown previously and in Fig. 3A, PrgX is
sufficient and necessary for iCF10 to function as an inhibitor of
cCF10, at least at the peptide levels used in these experiments.
We have been unable to obtain data to indicate that the pres-
ence of PrgZ in responder cells enhances iCF10 activity to a
significant extent. Some of our data suggest that PrgZ expres-
sion actually decreased the ability of exogenous iCF10 to in-
hibit cCF10 (data not shown), suggesting that PrgZ might
enhance import of cCF10 but not iCF10; however, we cannot
rule out the possibility that the peptides could compete for
PrgZ under some conditions. It could be argued that these
concentrations are higher than those found in natural mating
mixtures, but it should be pointed out that PrgZ does signifi-
cantly enhance the response to cCF10 under the same condi-
tions (Fig. 3). While our cumulative data indicate that PrgX
may be the most important site of direct competition between
iCF10 and cCF10, the results shown in Fig. 3B and C confirm
that the net biological activity of cCF10 as a mating pheromone
depends on interactions with both PrgX and PrgZ.
The genetic screen carried out in this study identified 15
variants of cCF10 with amino acid substitutions. With a single
exception (V7I), determination of the relative pheromone ac-
tivities of all the synthetic cCF10 variants gave the same results
as those obtained in the assays of E. coli supernatants. Al-
though we limited our screen to testing about 600 clones from
a total of three independent transformations, we did identify
mutations resulting in the same amino acid sequence change in
multiple independent transformants. This suggests that, given
the phenotypic constraints used, we may have approached sat-
uration in this screen.
Relative to cCF10, all of the synthetic peptides had reduced
pheromone activity when tested against responder cells ex-
pressing PrgZ (Fig. 4 and 5). In most cases, the presence of
PrgZ increased the absolute inducing activities of the variants
in a fashion similar to that observed with cCF10. For the two
peptides (T3S and F6Y) whose activity was not enhanced by
PrgZ, it was concluded that the substitutions probably had no
deleterious effects on the peptide interactions with PrgX (and
even enhanced this interaction slightly in the case of F6Y).
However, these variants had a reduced productive interaction
with PrgZ, with the overall effect being a slight reduction of
pheromone activity when the responder cells expressed both
PrgZ and PrgX. Peptide V7I had a much higher increase in
inducing activity when assayed against p043lacZ-containing re-
sponder cells containing PrgZ than all the other peptides,
including native cCF10. In this case the mutation probably
FIG. 5. PrgZ effects on p043lacZ induction ability of peptides. Syn-
thetic cCF10 variant peptides were added at 5 ng/ml to cCF10-deficient
strain JRC104 harboring p043lacZ with a second plasmid express-
ing PrgZ from pMSP6043-1 (Z, dark bars) or a vector control,
pMSP6043-2 (Z, light bars). Peptides were added immediately after
a 1:5 dilution from stationary-phase cultures, and -galactosidase in-
duction levels were measured after 90 min incubations. Data shown
are representative of at least two independent experiments done in
duplicate; error bars represent one standard deviation of the mean.
1404 FIXEN ET AL. J. BACTERIOL.
 on N
ovem







enhanced a productive interaction with PrgZ, resulting in in-
creased import into the responder cell, but at the same time
the interaction with PrgX was impaired slightly, reducing the
overall activity. The molecular nature of “productive” peptide/
PrgZ interaction that was affected in peptides T3S, F6Y, and
V7I is essentially unknown. One formal possibility is that the
optimal interactions could increase the binding affinity of the
peptide for PrgZ. However kinetic studies of oligopeptide per-
mease-mediated peptide import in Lactococcus lactis by the
Poolman group (32) suggested the possibility that release of
previously bound peptide from the OppA binding protein
(PrgZ is an OppA homolog specific for cCF10) into the trans-
membrane channel formed by the other Opp components
could be the rate-limiting step in peptide import. Comparative
biochemical and structural studies of PrgZ interactions with
cCF10 and the three variant peptides discussed above could
help distinguish between these two possibilities. It is also for-
mally possible that certain amino acid substitutions could affect
efficiency of import by the chromosomal OppA binding pro-
tein, but we lack the tools to examine this possibility at present.
The majority of amino acid substitutions identified in this
study appeared to affect peptide/PrgX interactions. Since all of
these variants retained some pheromone activity but caused no
detectable inhibition of cCF10, it is likely that they all pro-
duced structural changes in PrgX similar to those observed
with cCF10 but that the binding affinities were reduced or the
rotation of the C-terminal arm of PrgX that leads to destabi-
lization of tetramers occurred to a lesser extent. Previous struc-
tural studies of PrgX suggested that nearly all of the hydrogen
bonding interactions between the peptide and residues in the
C-terminal domain of PrgX involve the peptide backbone, and
this is also the case for many of the interactions between the
peptide and the PrgX residues lining the binding pocket. This
is consistent with the fact that there are almost no charged side
groups in any of the residues of cCF10 or iCF10. The hydro-
phobic side chains of these peptides likely affect PrgX interac-
tions either by providing spatial constraints or by affecting the
binding affinity. The available structural data suggest some
explanations for the results presented here. For example, the
L4V substitution, which reduced the inducing activity by
	95% in responder cells lacking PrgZ (Fig. 5), replaced a large
hydrophobic side chain with a smaller one. The three-carbon
valine side chain of L4V would easily fit within the space
occupied by four-carbon leucine side chain of cCF10, and the
formation of an important hydrogen bond between the peptide
backbone and PrgX residue Y298 (39) should not be impaired
in the variant. However, the smaller side chain would probably
confer weaker hydrophobic interactions with the binding
pocket, reducing affinity of the peptide for PrgX. Similar lines
of reasoning can be used to suggest structural interactions to
account for the activities of the other variant peptides, includ-
ing F6Y, where the extra hydroxyl group on the aromatic side
chain would not appear to cause any spatial problems and
might actually provide an additional hydrogen bond with PrgX
to stabilize the complex, accounting for its increased inducing
activity (in cells lacking PrgZ). As noted above, these kind of
predictions need to be verified experimentally. Our efforts to
obtain quantitative solution binding affinity data have been
hampered by the tendency for the peptides and protein to
precipitate from aqueous solutions and to stick nonspecifically
to dialysis membranes and other surfaces, but further struc-
tural and biochemical studies on these peptides are in progress.
Genetic analyses of signaling peptide specificity have been
carried out in a few other systems, generally those involving
membrane histidine kinase peptide receptors (12, 26, 27, 34).
For the pneumococcal competence-stimulating peptide, ge-
netic analyses have been coupled with solution structural anal-
yses using spectroscopic techniques (27). In the case of the
enterococcal pheromone peptides, the biological activities of
synthetic peptides selected based on visual inspection of native
pheromone sequences have been tested (28), but this was done
before the identities of the sex pheromone receptors were
actually proven. In the pAD1 system, An and Clewell synthe-
sized cAD1 variants containing single alanine substitutions at
each nonalanine residue and found that all of these except
V5A dramatically reduced pheromone activity (2). The present
study provides peptide reagents with a range of biological
activities for a comprehensive high-resolution structure/func-
tion analysis of the pCF10 cell-cell signaling system.
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